JPY2,603.00
1.74% yesterday
Tokyo, Jun 13, 08:15 am CET
ISIN
JP3546800008
Symbol
4543
Index
Sector

Terumo Stock price

JPY2,609.00
-175.50 6.30% 1M
-442.00 14.49% 6M
-453.00 14.79% YTD
-8.50 0.32% 1Y
+638.50 32.40% 5Y
+1,896.50 266.18% 10Y
+2,225.25 579.87% 20Y
Tokyo, Closing price Fri, Jun 13 2025
-40.00 1.51%
ISIN
JP3546800008
Symbol
4543
Index
Sector

Key metrics

Market capitalization JPY3.92t
Enterprise Value JPY3.87t
P/E (TTM) P/E ratio 33.40
EV/FCF (TTM) EV/FCF 30.12
EV/Sales (TTM) EV/Sales 3.73
P/S ratio (TTM) P/S ratio 3.78
P/B ratio (TTM) P/B ratio 2.85
Dividend yield 1.13%
Last dividend (FY26) JPY30.00
Revenue growth (TTM) Revenue growth 12.40%
Revenue (TTM) Revenue JPY1.04t
EBIT (operating result TTM) EBIT JPY157.67b
Free Cash Flow (TTM) Free Cash Flow JPY128.44b
Cash position JPY222.26b
EPS (TTM) EPS JPY79.30
P/E forward 26.88
P/S forward 3.67
EV/Sales forward 3.63
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Terumo forecast:

12x Buy
71%
5x Hold
29%

Analyst Opinions

17 Analysts have issued a Terumo forecast:

Buy
71%
Hold
29%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,036,171 1,036,171
12% 12%
100%
- Direct Costs 475,501 475,501
8% 8%
46%
560,670 560,670
17% 17%
54%
- Selling and Administrative Expenses 381,648 381,648
11% 11%
37%
- Research and Development Expense - -
-
-
243,117 243,117
12% 12%
23%
- Depreciation and Amortization 85,449 85,449
11% 11%
8%
EBIT (Operating Income) EBIT 157,668 157,668
13% 13%
15%
Net Profit 116,978 116,978
10% 10%
11%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 28,294
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today